IMRN Immuron Ltd

2.17

0.00 (0.00%)

Pre Market

Last Updated: 11:18:22

Delayed by 15 minutes

Name	Symbol	Market	Type
Immuron Ltd	NASDAQ:IMRN	NASDAQ	Depository Receipt

	Price Change	% Change	Price	Bid Price	Offer Price	High Price	Low Price	Open Price	Traded	Last Trade
	0.00	0.00%	2.17	2.05	2.40				0	11:18:22

Immuron CEO, Steven Lydeamore to present at Bioshares

24/07/2023 11:00am

GlobeNewswire Inc.

Immuron (NASDAQ:IMRN)
Historical Stock Chart

From Jun 2023 to Jun 2024

Immuron Limited (ASX: IMC; NASDAQ: IMRN), an Australian based and globally integrated biopharmaceutical company is pleased to advise our Chief Executive Officer, Steven Lydeamore will be presenting at the 17th Bioshares Biotech Summit in Hobart, Australia on July 24th.

A copy of the presentation slide deck is available on the Company’s website.

https://www.immuron.com.au/corporate-presentations/

This release has been authorised by the directors of Immuron Limited.

COMPANY CONTACT:

Steven LydeamoreChief Executive OfficerPh: +61 (0)3 9824 5254info@immuron.com

About ImmuronImmuron Limited (ASX: IMC, NASDAQ: IMRN), is an Australian biopharmaceutical company focused on developing and commercialising orally delivered targeted polyclonal antibodies for the treatment of infectious diseases.

For more information visit: http://www.immuron.com